Business, Drugs and Pharmaceuticals, Free News Articles

BioAdaptives, Inc. Announces Return to Fully Reporting and Appointment of President

LAS VEGAS, Nev. -- BioAdaptives, Inc. (OTC BB: BDPT) announced the Company's return to a fully-reporting entity, and the appointment of Mr. Robert W. Ellis as its new President, reporting to Dr. Edward E. Jacobs, Jr.

Dr. Jacobs, Director and CEO said, "We are very pleased to again be an SEC fully-reporting Company, even though when it ceased reporting on EDGAR during 2017 and 2018, the Company continued to release full disclosure data via OTC Market's alternate reporting format."

Dr. Jacobs added, "We are also pleased to announce the appointment of Mr. Robert W Ellis to our Management team. With his additional, it allows me the opportunity to spend more time on the strategic development of BioAdaptives, and to continue scientific research and advancement of a broad line of wellness products for people and animals."

"Mr. Ellis brings more than forty years of business management experience to this new assignment. He has held senior financial and operating management positions in aerospace and telecommunication public corporations, as well as private companies in both mature technology business and development-stage entities," Dr. Jacobs further added.

Mr. Ellis stated, "I am pleased to join BioAdaptives in this position and look forward to leading the Company as it emerges further from its development stage and matures into a growing successful manufacturing and distribution company. We expect to expand BioAdaptives operation through acquisitions and subsidiary entities in its current natural wellness sphere and in related fields in order to add to the Company's bottom line."

About BioAdaptives, Inc.:

BioAdaptives, Inc. is a fully-reporting, public company trading on the OTC Bulletin Board under the symbol BDPT. The company is engaged in research and development in science-based nutraceutical products for human and animal consumption. Learn more at:


Forward-Looking Statements: This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of BioAdaptives, Inc. and its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond BioAdaptives, Inc.'s ability to control, and actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in BioAdaptives, Inc.'s filings with the Securities and Exchange Commission.


Related link:

This news story was published by the Neotrope® News Network - all rights reserved.

Free News Articles, Product Launches

Extreme Muscle Products Launches First Formulation

AURORA, Colo. -- Extreme Muscle Products (EMP) today announced the launch of its first formulation available for purchase, a product called Q-Meric.

EMP is a newly created Colorado-based company focusing on health, wellness and athletic performance, with an emphasis on products that have synergistic effects. This means the ingredients in the products work more effectively together than if taken separately. Q-Meric is a blend of Turmeric, CoenzymeQ10 (CoQ10) and pyrroloquinoline quinone (PQQ).

"Q-Meric's ingredients were carefully chosen to offer heart protection, increased brain function and reduced inflammation, while serving as an antioxidant," said EMP founder and CEO Steven Skalkowski. "The ingredients work together to create new mitochondria while protecting cells from oxidative damage."

Mitochondria are known as the powerhouses of the cell. They act like a digestive system which takes in nutrients, breaks them down, and creates energy rich molecules for the cell.

"Creating new mitochondria means more potential energy," Skalkowski said. "This is revolutionary to the cells, especially in the heart and brain, where the highest amount of mitochondria reside. In particular, PQQ is a powerful nootropic and unique to cognitive brain health for its connection to nerve growth. PQQ has been effective in improving induction of nerve cells in sciatic-nerve-deficit animal models."

Q-Meric is the first of many products Skalkowski is excited about sharing.

"Health and fitness are my life's passions," Skalkowski said. "Whatever your athletic goals may be, I believe you must first take care of your overall health before you expect your body to respond to intense training and activity. Think of building a magnificent skyscraper, but your foundation is shaky. That building will collapse, just like your body if you don't have a good foundation. EMP products will provide that sound foundation."

Extreme Muscle Products is a company devoted to health and wellness, bringing to market only products with good synergistic effects.

Q-Meric can be purchased at

*LOGO for Media:

*VIDEO (YouTube):

*Disclaimer: These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease or illness. Always consult your physician before beginning any exercise or supplement program.

This news story was published by the Neotrope® News Network - all rights reserved.